Tysabri may be more effective than Gilenya at reducing disease activity in MS patients, study says
An indirect comparison of results from randomised clinical trials in relapsing-remitting multiple sclerosis patients suggests that Tysabri (natalizumab) is more effective than Gilenya (fingolimod) at reducing disease activity...Read more - http://www.ms-uk.org/tysabri-may-be-mor ... ays-071016
Tysabri may be more effective than Gilenya...
Tysabri may be more effective than Gilenya...
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 5 Replies
- 14759 Views
-
Last post by gibbledygook
-
- 9 Replies
- 15501 Views
-
Last post by ElliotB
-
- 0 Replies
- 2220 Views
-
Last post by NHE
-
- 0 Replies
- 11128 Views
-
Last post by NHE